『The Lancet HIV in conversation with』のカバーアート

The Lancet HIV in conversation with

The Lancet HIV in conversation with

著者： The Lancet Group
無料で聴く

Peter Hayward, Editor-in-Chief, and Adrian Gonzalez-Lopez, Senior Editor at The Lancet HIV, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from treatments of children with HIV to COVID-19 and chemsex, the experiences of HIV among global Indigenous populations to intimate partner violence and women with HIV, and more.© 2026 The Lancet Group 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Annemarie Wensing, Tommaso Clemente, and Arjen Stam on clinical management of persistent low-level viremia in people on antiretroviral therapy

    Annemarie Wensing, Tommaso Clemente, and Arjen Stam on clinical management of persistent low-level viremia in people on antiretroviral therapy
    2026/07/01

    Some people on HIV treatment have a viral load that won't fully suppress. In this episode, we speak with Annemarie Wensing (University Medical Center Utrecht in The Netherlands and Witwatersrand University in South Africa), Aryen Stam (University Medical Center Utrecht) and Tomasso Clemente (IRCCS San Raffaele Scientific Institute in Milan, Itally); authors of an international consensus published in The Lancet HIV, bringing together nearly 100 experts across six continents to tackle one of the least standardized challenges in HIV care: low-level viremia. What does the evidence actually say about risk? When should a clinician act? How to communicate a low-level viremia diagnosis to a patient? And what does this guidance mean for the people being treated in settings where resistance testing and second-line options are out of reach?

    Click here to read the full article:

    https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00107-4/fulltext
    続きを読む 一部表示
    19 分
  • David Coelho and Arjee Restar on mental health disparities among transgender women and transfeminine people living with HIV

    David Coelho and Arjee Restar on mental health disparities among transgender women and transfeminine people living with HIV
    2026/06/15

    Transgender women and transfeminine people living with HIV face layers of stigma and multiple challengers that contribute to high levels of mental ill health and substance use—new research quantifies this burden, and we discuss the findings with the authors and explore drivers and solutions.

    Click here to read the full article:

    https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00004-4/fulltext
    続きを読む 一部表示
    30 分
  • Esteban Martinez and Steven Grinspoon on non-communicable diseases and the REPRIEVE trial

    Esteban Martinez and Steven Grinspoon on non-communicable diseases and the REPRIEVE trial
    2026/04/29

    Non-communicable diseases (NCDs) increasingly represent a leading cause of morbidity and mortality among people with HIV. People with HIV are at high risk of developing NCDs, often at younger ages and more severely than people without HIV.

    Esteban Martinez from the Hospital Clinic and University of Barcelona, and Steven Grinspoon from the Massachusetts General Hospital and Harvard Medical School, join us to explore the importance of NCDs and how data from the REPRIEVE trial can help us understand and prevent the underlying causes increasing the risk of NCDs in people with HIV.

    Click here to read the full articles:

    https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00031-7/fulltext https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00354-6/fulltext https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00036-6/fulltext
    続きを読む 一部表示
    26 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません